Shariat SF - Search Results

1

Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M. Shariat SF, et al. Eur Urol. 2012 Feb;61(2):237-42. doi: 10.1016/j.eururo.2011.10.011. Epub 2011 Oct 21. Eur Urol. 2012. PMID: 22033174

2

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: shariat sf. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

3

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.

Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Andrews B, et al. Among authors: shariat sf. J Urol. 2002 Mar;167(3):1475-81. J Urol. 2002. PMID: 11832773

4

Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.

Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 Feb;61(2):359-64. doi: 10.1016/s0090-4295(02)02253-7. Urology. 2003. PMID: 12597948

5

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

6

Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.

Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP. Matsumoto K, et al. Among authors: shariat sf. J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17. J Urol. 2003. PMID: 14634390

7

Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.

Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, Cadeddu JA, McConnell JD, Holmes MN, Roehrborn CG. Shariat SF, et al. J Urol. 2004 Mar;171(3):1122-7. doi: 10.1097/01.ju.0000113249.82533.28. J Urol. 2004. PMID: 14767284

8

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.

Shariat SF, Casella R, Wians FH Jr, Ashfaq R, Balko J, Sulser T, Gasser TC, Sagalowsky AI. Shariat SF, et al. Eur Urol. 2004 Mar;45(3):304-13; author reply 313. doi: 10.1016/j.eururo.2003.10.020. Eur Urol. 2004. PMID: 15036675

9

Stage specific lymph node metastasis mapping in radical cystectomy specimens.

Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Vazina A, et al. Among authors: shariat sf. J Urol. 2004 May;171(5):1830-4. doi: 10.1097/01.ju.0000121604.58067.95. J Urol. 2004. PMID: 15076287

10

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. Among authors: shariat sf. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,905 results

Search Page

Filters